Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-25T01:50:56.610Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science (November 2005)

Published online by Cambridge University Press:  22 March 2006

R. Sutherland  and
J. Scorer
R. Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
J. Scorer
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 9 , Issue 4 , April 2006 , pp. 1 - 4 , e18
Copyright
2006 Cambridge University Press

References

Agarwal B, Saxena R, Morimiya A, Mehrotra S, Badve S. Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 2005; 29: 1449–1455.Google Scholar
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, Ambrosone CB. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162: 943–952.Google Scholar
Benlimame N, He Q, Jie S, Xiao DZ, Xu YJ, Loignon M, Schlaepfer DD, Alaoui-Jamali MA. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol 2005; 171: 505–516.Google Scholar
Berglund P, Stighall M, Jirstrom K, Borgquist S, Sjolander A, Hedenfalk I, Landberg G. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers. Cancer Res 2005; 65: 9727–9734.Google Scholar
Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, Shupnik MA. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Mol Endocrinol 2005; 19: 2660–2670.Google Scholar
Burger AM, Gao YG, Amemiya Y, Kahn HJ, Kitching R, Yang YL, Sun P, Narod SA, Hanna WM, Seth AK. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res 2005; 65: 10401–10412.Google Scholar
Cully M, Shiu J, Piekorz RP, Muller WJ, Done SJ, Mak TW. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis. Cancer Res 2005; 65: 10363–10370.Google Scholar
Dabrosin C. Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo. Clin Cancer Res 2005; 11: 8036–8041.Google Scholar
Daosukho C, Ittarat W, Lin SM, Sawyer DB, Kiningham K, Lien YC, St Clair DK. Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM). J Mol Cell Cardiol 2005; 39: 792–803.Google Scholar
Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang XB, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. RelB/p52 NF-kappa B complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor I kappa B-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol 2005; 25: 10136–10147.Google Scholar
Dietze EC, Bowie ML, Mrozek K, Caldwell LE, Neal C, Marjoram RJ, Troch MM, Bean GR, Yokoyama KK, Ibarra CA, Seewaldt VL. CREB-binding protein regulates apoptosis and growth of HMECs grown in reconstituted ECM via laminin-5. J Cell Sci 2005; 118: 5005–5022.Google Scholar
Frank B, Hemminki K, Shanmugam KS, Meindl A, Klaes R, Schmutzler RK, Wappenschmidt B, Untch M, Bugert P, Bartram CR, Burwinkel B. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk. Carcinogenesis 2005; 26: 1975–1977.Google Scholar
Graham JD, Yager ML, Hill HD, Byth K, O'Neill GM, Clarke CL. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol Endocrinol 2005; 19: 2713–2735.Google Scholar
Grainger DJ, Schofield PM. Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence. Circulation 2005; 112: 3018–3024.Google Scholar
Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: Results from the postmenopausal estrogen/ progestin interventions mammographic density study. Am J Epidemiol 2005; 162: 826–834.Google Scholar
Gyorffy B, Serra V, Jurchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schafer R. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Oncogene 2005; 24: 7542–7551.Google Scholar
Hodgson JG, Malek T, Bornstein S, Hariono S, Ginzinger DG, Muller WJ, Gray JW. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res 2005; 65: 9695–9704.Google Scholar
Howe LR, Chang SH, Tolle KC, Dillon R, Young LJT, Cardiff RD, Newman RA, Yang PY, Thaler HT, Muller WJ, Hudis C, Brown AMC, Hla T, Subbaramaiah K, Dannenberg AJ. HER2/ neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res 2005; 65: 10113–10119.Google Scholar
Huang J, Li XD, Maguire CA, Hilf R, Bambara RA, Muyan M. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus. Mol Endocrinol 2005; 19: 2696–2712.Google Scholar
Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, Penuela JM, Udvarhely N, El Makdissi G, Ginestier C, Geneix J, Charafe-Jauffret E, Xerri L, Eisinger F, Birnbaum D, Sobol H, The European Working Group for Breast Screening Pathology, the Breast Cancer Linkage Consortium. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 2005; 207: 260–268.Google Scholar
Jirstrom K, Ryden L, Anagnostaki L, Nordenskjold B, Stal O, Thorstenson S, Chebil G, Jonsson PE, Ferno M, Landberg G. Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial. J Clin Pathol 2005; 58: 1135–1142.Google Scholar
Johnson KC. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 2005; 117: 619–628.Google Scholar
Jung SS, Park HS, Lee IJ, Namkoong H, Shin SM, Cho GW, Ha SA, Park YG, Lee YS, Ko JS, Kim JW. The HCCR oncoprotein as a biomarker for human breast cancer. Clin Cancer Res 2005; 11: 7700–7708.Google Scholar
Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res 2005; 65: 10265–10272.Google Scholar
Kim H, Chan R, Dankort DL, Zuo DM, Najoukas M, Park M, Muller WJ. The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Oncogene 2005; 24: 7599–7607.Google Scholar
Knowlden JM, Hutcheson IR, Barrow D, Gee JMW, Nicholson RI. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor. Endocrinology 2005; 146: 4609–4618.Google Scholar
Lagiou P, Samoli E, Lagiou A, Hsieh CC, Adami HO, Trichopoulos D. Maternal height, pregnancy estriol and birth weight in reference to breast cancer risk in Boston and Shanghai. Int J Cancer 2005; 117: 494–498.Google Scholar
Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH. Up-regulation of P13K/Akt signaling by 17 beta-estradiol through activation of estrogen receptor-alpha but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem Biophys Res Commun 2005; 336: 1221–1226.Google Scholar
Leo JCL, Wang SM, Guo CH, Aw SE, Zhao Y, Li JM, Hui KM, Lin VCL. Gene regulation profile reveals consistent anticancer properties of progesterone in Hormone-independent breast cancer cells transfected with progesterone receptor. Int J Cancer 2005; 117: 561–568.Google Scholar
Lester RD, Jo M, Campana WM, Gonias SL. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 2005; 280: 39273–39277.Google Scholar
Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem 2005; 280: 38639–38647.Google Scholar
Menendez JA, Vellon L, Colomer R, Lupu R. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. J Natl Cancer Inst 2005; 97: 1611–1615.Google Scholar
Monzavi-Karbassi B, Whitehead TL, Jousheghany F, Artaud C, Hennings L, Shaaf S, Slaughter A, Korourian S, Kelly T, Blaszczyk-Thurin M, Kieber-Emmons T. Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer. Int J Cancer 2005; 117: 398–408.Google Scholar
Prentice LM, Shadeo A, Lestou VS, Miller MA, DeLeeuw RJ, Makretsov N, Turbin D, Brown LA, Macpherson N, Yorida E, Cheang MCU, Bentley J, Chia S, O Nielsen T, Gilks CB, Lam W, Huntsman DG. NRG1 gene rearrangements in clinical breast cancer: identication of an adjacent novel amplicon associated with poor prognosis. Oncogene 2005; 24: 7281–7289.Google Scholar
Saitoh M, Ohmichi M, Takahashi K, Kawagoe J, Ohta T, Doshida M, Takahashi T, Igarashi H, Mori-Abe A, Du BT, Tsutsumi S, Kurachi H. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappa B cascade in human breast cancer cells. Endocrinology 2005; 146: 4917–4925.Google Scholar
Samuelson DJ, Aperavich BA, Haag JD, Gould NN. Fine mapping reveals multiple loci and a possible epistatic interaction within the mammary carcinoma susceptibility quantitative trait locus, Mcs5. Cancer Res 2005; 65: 9637–9642.Google Scholar
Sartorius CA, Harvell DME, Shen TJ, Horwitz KB. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res 2005; 65: 9779–9788.Google Scholar
Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol 2005; 19: 2671–2684.Google Scholar
Shetty A, Loddo M, Fanshawe T, Prevost AT, Sainsbury R, Williams GH, Stoeber K. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 2005; 93: 1295–1300.Google Scholar
Singh RR, Barnes CJ, Talukder AH, Fuqua SAW, Kumar R. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Res 2005; 65: 10594–10601.Google Scholar
Suzuki R, Ye WM, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: A prospective cohort study. J Natl Cancer Inst 2005; 97: 1601–1608.Google Scholar
Tari AM, Simeone AM, Li YJ, Gutierrez-Puente Y, Lai SL, Symmans WF. Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl) retinamide inhibitory effects in breast cancer cells. Lab Invest 2005; 85: 1357–1367.Google Scholar
Taverna D, Crowley D, Connolly M, Bronson RT, Hynes RO. A direct test of potential roles for beta 3 and beta 5 integrins in growth and metastasis of murine mammary carcinomas. Cancer Res 2005; 65: 10324–10329.Google Scholar
Tian KG, Jurukovski V, Wang XP, Kaplan MH, Xu HP. Epigenetic regulation of WTH3 in primary and cultured drug-resistant breast cancer cells. Cancer Res 2005; 65: 10024–10031.Google Scholar
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Br J Cancer 2005; 93: 1128–1136.Google Scholar
Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Tumor lymphangiogenesis in inflammatory breast carcinoma: A histomorphometric study. Clin Cancer Res 2005; 11: 7637–7642.Google Scholar
Wang L, Devarajan E, He J, Sekhar PRY, Le Dai J. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. Cancer Res 2005; 65: 10289–10297.Google Scholar
Wang TL, Tamae D, LeBon T, Shively JE, Yen Y, Li JJ. The role of peroxiredoxin II in radation-resistant MCF-7 breast cancer cells. Cancer Res 2005; 65: 10338–10346.Google Scholar
Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K. Changes in cytoskeletal protein composition indicative of an epithelial–mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005; 11: 8006–8014.Google Scholar
Wirtenberger M, Hemminki K, Forsti A, Klaes R, Schmutzler RK, Grzybowska E, Bermejo JL, Wappenschmidt B, Bugert P, Butkiewicz D, Pamula J, Pekala W, Zientek H, Bartram CR, Burwinkel B. C-MYC Asn11Ser is associated with increased risk for familial breast cancer. Int J Cancer 2005; 117: 638–642.Google Scholar
Wu LC, Tannock IF. Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapy. Clin Cancer Res 2005; 11: 8195–8200.Google Scholar
Yang XH, Liu DH, Murray TJ, Mitchell GC, Hesterman EV, Karchner SI, Merson RR, Hahn ME, Sherr DH. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cell. Oncogene 2005; 24: 7869–7881.Google Scholar
Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005; 20: 539–550.Google Scholar